Skip to main content
. 2016 Sep 26;6(9):e011471. doi: 10.1136/bmjopen-2016-011471

Figure 4.

Figure 4

Cumulative incidence of non-persistence among OAC naïve patients. OAC, oral anticoagulants; VKA, vitamin K antagonists.